Accelerated Treatment of Depressive Patients With tDCS
NCT: NCT07444242 · RECRUITING
Brief Summary
A randomized, controlled three-arm study is planned to investigate the effectiveness and feasibility of an accelerated home-based tDCS application (3 weeks of transcranial direct current stimulation at home, twice daily). A total of 30 patients with depression (10 per group), who are currently not taking and have no history of taking antidepressant medication, will be randomly assigned to either an active tDCS condition, a sham (placebo) tDCS condition, or a waitlist control group. The latter two groups will receive active tDCS treatment after completion of the control phase. This study represents a continuation of the pilot study GSUND DAHOAM (Ethics approval: 20-2091-101; Dragon et al., 2024).
Frequently Asked Questions
What is Accelerated Treatment of Depressive Patients With tDCS?
Accelerated Treatment of Depressive Patients With tDCS is a clinical trial registered under NCT07444242. Current status: RECRUITING.
What is the status of NCT07444242?
The current status of NCT07444242 (Accelerated Treatment of Depressive Patients With tDCS) is: RECRUITING.
When did Accelerated Treatment of Depressive Patients With tDCS start?
Accelerated Treatment of Depressive Patients With tDCS started on 2026-04-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.